Processing .....please wait.. 
The article has been forwarded.... 
Ranbaxy taking drugs to US, UK for trials
By siliconindia
|
Thursday, 25 September 2003, 19:30 IST
NEW DELHI: IndiaÂ’s largest exporter of drugs, Ranbaxy Laboratories, on Wednesday said it will take some more of its products under development for trials to the United States, Britain and Canada.
Ranbaxy, which recently tied up with Schwarz Pharma AG for development of its new drug RBX 2258 for the treatment of benign prostatic hyperplasic, said it is considering taking some drugs under development for trials in the US and the UK.
“We have five to six products under various phases of clinical trials and we will take some of them to the US and UK,” Ranbaxy CEO and managing director D S Brar said.